Columbia-Coulter Biomedical Accelerator
We are very pleased to announce that the Columbia-Coulter Translational Research Partnership is currently accepting Pre-Proposals for the next application cycle (i.e. 2017 funding). (Although Coulter Foundation funding is coming to an end, we are able to sustain the program for an additional year and are working on longer term financial support.)
All biomedical technologies with the potential to directly impact human health will be considered (e.g. therapeutic drugs and devices, medical imaging, monitoring devices, biosensors, biomaterials, and platform technologies). Most relevant are technologies in which the time to market can be achieved in 7 to 10 years. To be eligible, the project/technology must be an idea or invention based on Columbia intellectual property.
Eligible teams must include both an engineer/scientist and a clinician, and at least one PI must have a faculty appointment at Columbia. If you need an engineering or clinical collaborator, we may be able to facilitate introductions. Please email matchmaking requests to coulter@columbia.edu by November 1, 2016.
Pre-Proposals are due by Thursday, December 1, 2016.
We very much appreciate your help amplifying the Columbia-Coulter Call for Pre-Proposals. Please feel free to forward this to any of your PIs who you think might benefit from the program. Details are below. We’re also hosting information sessions next week and in mid-October, and potential applicants are always welcome to reach out to us directly at coulter@columbia.edu.
INFO SESSION
CUMC
- Wednesday, October 19th, 4pm, Presbyterian Hospital Building, 10th Floor, Room 204, Irving Institute Conference Room (PH-10-204) (Click HERE to RSVP)
If you have any questions, please email us at coulter@columbia.edu
For more information on the application process, click HERE.
